Publications
43
Citations
609
Est. group size
~14
Recurring co-author estimate
Active years
11
Publishing since 2016
Adrian C. Eddy's research focuses on preeclampsia, a dangerous high-blood-pressure disorder that can develop during pregnancy, and the underlying placental and vascular problems that cause it. Much of the work examines how molecules like sFlt-1 (a protein linked to blood vessel dysfunction) and the plant-derived compound luteolin affect placental cells, blood vessels, and blood pressure in animal and cell-culture models. Related work also touches on anti-inflammatory therapeutics, fertility protection strategies, and other cardiovascular and endocrine signaling molecules.
Publication output has fluctuated over the past decade, with a peak in 2018 and another notable rise in 2023, averaging about 4 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia
Placenta · 2026
- Bioflavonoid luteolin inhibits relevant preeclamptic inflammatory and oxidative stress pathways in vitro
Pregnancy Hypertension · 2024
- Luteolin prevents TNF-α-induced NF-κB activation and ROS production in cultured human placental explants and endothelial cells
Placenta · 2023
- Fertility Protection, A Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect against Chemotherapy-Induced Testicular Cytotoxicity
International Journal of Molecular Sciences · 2023
- Bioflavonoid luteolin prevents <scp>sFlt</scp> ‐1 release via <scp>HIF</scp> ‐1α inhibition in cultured human placenta
The FASEB Journal · 2023
- Treatment with the flavonoid, luteolin, attenuates the development of placental ischemia-induced hypertension in pregnant rats
Physiology · 2023
- Bioflavonoid luteolin normalizes pathways implicated in preeclampsia vascular dysfunction
Physiology · 2023
- Bioflavonoid luteolin prevents sFlt-1 release via HIF-1α inhibition in cultured human placenta
Open MIND · 2023
- Bioflavonoid luteolin prevents sFlt-1 release via HIF-1α inhibition in cultured human placenta
University of Chicago · 2023
- Growth differentiation factor-15 and its role in diabetes and cardiovascular disease
Cytokine & Growth Factor Reviews · 2020
- Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells
Bioscience Reports · 2020
- Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia
Hypertension · 2019
- Heparanase regulation of sFLT-1 release in trophoblasts in vitro
Placenta · 2019
- Abstract P3045: The ELP-VEGF Fusion Protein Is Bioavailable After Subcutaneous Administration And Prevents Increased Blood Pressure In Response To Placental Ischemia
Hypertension · 2019
- sFlt‐1 Splicing Regulation by U2AF65 and JMJD6 in Endothelial Cells
The FASEB Journal · 2019
- bioRxiv (Cold Spring Harbor Laboratory)×7
- The FASEB Journal×6
- Hypertension×5
- Pregnancy Hypertension×5
- Nature Communications×3
- Laura S. Haneline
Medicine · Indiana University
- Mark A. Klebanoff
Medicine · The Ohio State University
- Cindy M. Anderson
Medicine · The Ohio State University
- Maged M. Costantine
Medicine · The Ohio State University
- Melissa L. Wilson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile